Mr. Bryan Baldasare - 12 May 2022 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Director
Signature: /s/ Eric Adams, attorney-in-fact for Mr. Bryan Baldasare
Issuer symbol: INM
Transactions as of: 12 May 2022
Net transactions value: $0
Form type: 3
Filing time: 19 May 2022, 16:22:23 UTC
Previous filing: 22 Dec 2021
Next filing: 19 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney